SCHEMBL16169013

SCHEMBL16169013

CC(C)[C@H](N)c1cc(F)cc(F)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.35
TDO2 P48775 1/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
DPP4 P27487 2/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA9 Q16790 1/20 0.32
NR1I2 O75469 1/20 0.31
TRPM8 Q7Z2W7 1/20 0.31
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
OPRK1 P41145 1/20 0.31
OPRL1 P41146 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
DPP7 Q9UHL4 1/20 0.31
GBA1 P04062 2/20 0.30
AOC3 Q16853 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12569044 0.84 IDO1 (0.40) IDO1TDO2CES2CES1DPP4
SCHEMBL24017071 0.84 IDO1 (0.40) IDO1TDO2CES2CES1DPP4
SCHEMBL12568805 0.84 IDO1 (0.40) IDO1TDO2CES2CES1DPP4
SCHEMBL1728961 0.79 IDO1 (0.42) IDO1TDO2CES2CES1CA12
SCHEMBL1004099 0.79 IDO1 (0.42) IDO1TDO2CES2CES1CA12
SCHEMBL557913 0.79 IDO1 (0.42) IDO1TDO2CES2CES1CA12
SCHEMBL12261672 0.78 AOC3 (0.47) IDO1TDO2CES2CES1OPRM1
SCHEMBL16168995 0.78 AOC3 (0.47) IDO1TDO2CES2CES1OPRM1
Hydrochloric Acid SCHEMBL16341078 0.77 IDO1 (0.45) IDO1TDO2CES2CES1CA12
Hydrochloric Acid SCHEMBL1876903 0.77 IDO1 (0.45) IDO1TDO2CES2CES1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051310-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2015-06-09 US disclosed
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, BTK, NOX4 IDO1 171/4885TDO2 3158/4885CES2 4022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.